FORBEARANCE AGREEMENTForbearance Agreement • July 17th, 2023 • Mallinckrodt PLC • Pharmaceutical preparations • New York
This FORBEARANCE AGREEMENT, dated as of July 16, 2023 (this “Agreement”), is by and among MALLINCKRODT INTERNATIONAL FINANCE S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 124, boulevard de la Pétrusse, L-2330 Luxembourg, and registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 172.865 (the “Issuer”), MALLINCKRODT CB LLC, a Delaware limited liability company (the “US Co-Issuer”, and, together with the Issuer, the “Issuers”), and noteholders beneficially owning, in the aggregate, a majority in principal amount of the outstanding Notes (as defined below) (the “Forbearing Holders,” and together with the Issuers, the “Parties,” any Issuer or Forbearing Holder individually a “Party”). Capitalized terms used but not otherwise defined in this Agreement have the same meanings as specified in the Indenture (as defined below).
FORBEARANCE AGREEMENTForbearance Agreement • July 17th, 2023 • Mallinckrodt PLC • Pharmaceutical preparations • New York
This FORBEARANCE AGREEMENT, dated as of July 16, 2023 (this “Agreement”), is by and among MALLINCKRODT PLC, a public limited company incorporated under the laws of Ireland with registered number 522227 (the “Parent” and, together with certain of its subsidiaries and affiliates, the “Company”), MALLINCKRODT INTERNATIONAL FINANCE S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 124, boulevard de la Pétrusse, L-2330 Luxembourg, and registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 172.865 (the “Lux Borrower”), MALLINCKRODT CB LLC, a Delaware limited liability company (the “Co-Borrower”, and, together with the Lux Borrower, the “Borrowers”), the LENDERS party hereto (the “Forbearing Lenders”), and Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents for the Lenders (in such capacities, together with their succ
FORBEARANCE AGREEMENTForbearance Agreement • July 17th, 2023 • Mallinckrodt PLC • Pharmaceutical preparations • New York
This FORBEARANCE AGREEMENT, dated as of July 16, 2023 (this “Agreement”), is by and among ST US AR FINANCE LLC, a Delaware limited liability company (the “Borrower”), BARCLAYS BANK PLC, as administrative agent and collateral agent (together with its successors and permitted assigns in such capacities, the “Agent”) and the Lenders comprising the Required Lenders signatory hereto. Capitalized terms used but not otherwise defined in this Agreement have the same meanings as specified in the Credit Agreement (as defined below).
FORBEARANCE AGREEMENTForbearance Agreement • July 17th, 2023 • Mallinckrodt PLC • Pharmaceutical preparations • New York
This FORBEARANCE AGREEMENT, dated as of July 16, 2023 (this “Agreement”), is by and among MALLINCKRODT INTERNATIONAL FINANCE S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 124, boulevard de la Pétrusse, L-2330 Luxembourg, and registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 172.865 (the “Issuer”), MALLINCKRODT CB LLC, a Delaware limited liability company (the “US Co-Issuer”, and, together with the Issuer, the “Issuers”), and noteholders beneficially owning, in the aggregate, over 75% in principal amount of the outstanding Notes (as defined below) (the “Forbearing Holders,” and together with the Issuers, the “Parties,” any Issuer or Forbearing Holder individually a “Party”). Capitalized terms used but not otherwise defined in this Agreement have the same meanings as specified in the Indenture (as defined below).
